About this guide, and why it contains no ranked list of named facilities. We do not accept payment for placement, we hold no referral relationships, and we are not going to hand you a “top ten” built from the marketing copy of the facilities themselves. No independent body publishes verified outcome data for private San Diego rehabs. Any ranking assembled from the outside would be a ranking of websites, not of care. What this page offers instead is the verification framework a general counsel would use, the specific federal and California laws that protect a chief executive who enters treatment, and the questions that separate a genuine executive program from an expensive one.
Last updated July 2026. This page has not been reviewed by a clinician and is not medical, legal or tax advice.
Why San Diego Became a Destination for Executive Addiction Treatment, and Why That Cuts Both Ways
San Diego sits in a very small club, alongside Malibu and Scottsdale, of American cities that people fly into specifically to go to rehab. The reasons are not mysterious. Coastal North County and La Jolla offer the kind of setting that makes a ninety-day absence explicable as a sabbatical. The clinical bench is deep, with UC San Diego Health, Scripps and Sharp anchoring a large population of addiction psychiatrists. And the airport is twenty minutes from downtown, which matters more than anyone admits when a board chair wants a face-to-face.
The flip side is that saturation attracts operators. San Diego has genuinely excellent programs and it has very expensive scenery with a clinical program bolted on. Both charge similarly. Both use the word “executive.” A chief executive walking into this market with a credit card and a crisis is, frankly, the most profitable customer in the industry, and the industry knows it.
So the question is not which facility has the best ocean view. It is which facility can survive twenty minutes of due diligence.
What the Federal Data Actually Says About Substance Use Disorder Among Full-Time Workers and Senior Professionals
Two numbers frame this entire conversation.
The first comes from SAMHSA’s analysis of the National Survey on Drug Use and Health, examining full-time employed adults aged 18 to 64 by industry. It found that 9.5 percent of full-time workers had a past-year substance use disorder. That is roughly one in ten people going to work every day. The report combined survey years from 2008 to 2012, so it is dated, and we flag that rather than dressing it up as current. It remains the most detailed federal breakdown of substance use disorder by industry that exists, and no one has replaced it.
The second number is current and, for anyone with the means to buy private care, worth sitting with. SAMHSA’s 2024 National Survey on Drug Use and Health found that among people aged 12 or older classified as needing substance use treatment in the past year, only about one in five received any treatment at all.
The American treatment gap, 2024
Needed substance use treatment and received it — 19.3%
Needed substance use treatment and received none — approx. 80.7%
Full-time workers aged 18–64 with a past-year substance use disorder — 9.5%
Sources: SAMHSA, 2024 National Survey on Drug Use and Health, for the treatment gap. SAMHSA, Substance Use and Substance Use Disorder by Industry, for the full-time worker figure, which combines survey years 2008 to 2012 and is presented here with that limitation stated. The third bar measures a different population from the first two and is not a subset of them.
Put those together and a specific truth emerges. If you are a chief executive with the resources to buy ninety days of private residential care in Del Mar, you are already, statistically, in an extraordinarily privileged position. The scarce resource in American addiction treatment is not luxury. It is access. That should inform how you judge a $200,000 quote, and it should also inform how seriously you take the opportunity.
The Confidentiality Law Almost No Executive Knows About: 42 CFR Part 2 and Why It Is Stronger Than HIPAA
This is the single most important section on this page, and if you read nothing else, read this.
Most executives assume HIPAA is the protection. It is not the strongest one. Substance use disorder treatment records held by a federally assisted treatment program are governed by a separate and older federal law, 42 U.S.C. 290dd-2 and 42 CFR Part 2. Part 2 was written in 1975 precisely because Congress understood that fear of professional and legal consequences was keeping people out of treatment.
The provision that matters to a chief executive is this. Part 2 records, and testimony relaying their contents, cannot be used or disclosed in civil, criminal, administrative or legislative proceedings against the patient without either the patient’s written consent or a court order issued after notice and an opportunity to be heard. HHS is explicit that this is a more stringent standard than HIPAA.
Think about what that means in a boardroom context. A hostile shareholder action. A divorce. A regulatory inquiry. A dispute with a co-founder. In each of those, an opposing party who wants your treatment records has to clear a bar that ordinary medical records do not impose.
The timing also matters, because this changed very recently. HHS finalized an updated Part 2 rule in 2024 implementing the CARES Act. The compliance date was February 16, 2026. On February 13, 2026, the HHS Office for Civil Rights announced a civil enforcement program for Part 2, began accepting complaints from February 16, and has made noncompliance an enforcement priority. Civil money penalties are on the table. Programs that were sloppy about this in 2024 do not have the luxury of being sloppy about it now.
Three questions this should put on your list.
Are you a Part 2 program? Not every private facility is federally assisted, and Part 2 attaches to federally assisted programs. Ask directly, and ask them to say it in writing.
Show me your updated Notice of Privacy Practices. The February 2026 rules required these to be revised to explain the heightened protections for substance use records. A program that cannot produce a current one has not done its homework on the law that protects you.
What does your consent form actually authorize? Under the revised rules a single consent can now cover future disclosures for treatment, payment and operations. That is administratively convenient and it is broader than what most people think they are signing. Read it. Have counsel read it.
And an honest limit, because a page that only tells you the good news is not a page you should trust. Part 2 protects records. It does not make you invisible. It does not stop a photographer outside the gate, it does not bind your spouse or your chief of staff, and it does not undo a disclosure you make voluntarily. Confidentiality is a legal architecture, not a force field.
Job Protection, Board Disclosure and the Employment Law Stack: What Actually Shields a C-Suite Executive in Treatment
Executives routinely overestimate their statutory protections and underestimate their contractual ones. Here is the honest map.
| Legal Protection | What It Covers | What It Does Not Cover |
|---|---|---|
| 42 CFR Part 2 | Treatment records held by a Part 2 program; bars use in legal proceedings against you absent consent or a court order | Anything you disclose yourself; observations by third parties; records held outside a Part 2 program |
| FMLA (29 CFR 825.119) | Up to 12 weeks of job-protected unpaid leave for inpatient treatment or continuing treatment by a provider, at eligible employers | Absences caused by use rather than treatment; discipline for conduct that occurred before the leave began |
| ADA | Alcoholism as a disability; people in supervised rehabilitation or who have completed it and are not currently using illegally; reasonable accommodations | Current illegal drug use; failure to meet the same performance standards applied to everyone else |
| Your employment agreement | Usually the document that actually governs a C-suite officer: leave terms, cause definitions, notice obligations, board reporting | Nothing, until you have read it. Most executives have not read theirs since signing |
Two points worth saying bluntly. First, FMLA and the ADA were not written with chief executives in mind, and for a senior officer with a negotiated contract, the contract will usually matter more than the statute. Second, if you sit at a public company, whether and when a board must be told anything is a securities and governance question. It belongs to outside counsel. It does not belong to a rehab admissions coordinator, and any facility that volunteers confident advice on it is telling you something about its judgment.
Talk to your own lawyer before you talk to your board. Not after.
How to Verify That a San Diego Executive Rehab Is Actually Licensed to Deliver What It Is Charging You For
California has a licensing quirk that essentially no luxury rehab website explains, and it should reshape your questions.
The California Department of Health Care Services has sole authority to license residential facilities providing alcohol and other drug recovery or treatment to adults. That license covers residential nonmedical services. It is not a hospital license. In the eyes of the state, a DHCS-licensed residential rehab is a nonmedical setting.
So how does anyone run medical detox? Either the facility holds approval to provide Incidental Medical Services, authorized under AB 848, which permits a health care practitioner to address medical issues associated with detoxification on site, or withdrawal management happens somewhere properly licensed as a health facility. Separately, under California Health and Safety Code section 11834.015, every licensed adult facility must hold at least one DHCS Level of Care Designation or a residential ASAM Level of Care Certification consistent with the services it actually provides.
| What to Verify | Why an Executive Should Care |
|---|---|
| DHCS license number and facility number | A beautiful house in La Jolla is not a treatment facility because its website says so. Check the state’s public list |
| Incidental Medical Services approval | If a nonmedical residential facility is charging you thousands a day for medical detox without IMS approval or hospital licensure, that is a regulatory problem, not a pricing one |
| ASAM level of care designation | ASAM 3.1, 3.3 and 3.5 are different products with different staffing. A 3.1 facility charging 3.5 prices is charging for care it is not designated to deliver |
| Joint Commission or CARF accreditation | Voluntary, independent, expensive to obtain. Its absence at a facility quoting $100,000 a month is a fair question to ask out loud |
| Named medical director with a verifiable California license | Board certification in addiction medicine or addiction psychiatry is checkable in about four minutes. Do it |
| How the person on the phone is compensated | Ask whether they are paid per admission. Patient brokering is a genuine problem in this market and a genuine legal exposure |
You can cross-check any San Diego facility against SAMHSA’s FindTreatment.gov directory, which is generated from the federal National Substance Use and Mental Health Services Survey. If you want the broader market picture first, our overview of luxury drug and alcohol rehab centers in San Diego covers the landscape by neighborhood and program type.
What an Executive Program Should Actually Include, and How to Spot One That Is Just a Private Room With a Laptop
“Executive track” is a marketing phrase before it is a clinical one. In a large share of programs it means precisely three things: a private bedroom, permission to keep your phone, and a two-hour window each afternoon to check email. That is not a clinical model. That is a concession.
A serious executive program looks different, and the differences are specific enough to ask about.
- Structured work access, not unlimited work access. The best programs treat device time as a clinical variable, negotiated and reviewed, not as an amenity. A program that lets you run your company from the patio is not treating you. It is hosting you.
- Psychiatric depth, not just counseling. Executive presentations are frequently co-occurring: alcohol layered over untreated anxiety, stimulant use layered over ADHD or a decade of sleep deprivation. If the psychiatrist visits weekly, the program is not built for this.
- Medication for opioid and alcohol use disorder, available on site. Buprenorphine, naltrexone and acamprosate are the most evidence-backed tools in addiction medicine. A luxury program that declines to offer them on philosophical grounds is selling an aesthetic, not medicine.
- A real family and organizational component. The relapse risk for a chief executive is usually embedded in the same environment that produced the disorder. If nobody is working on the return, the return will do the work on you.
- Aftercare with teeth. Ask what happens in months two through twelve, who owns it, and what it costs. This is where price and value diverge most sharply.
- Census, not square footage. Ask how many clients are in residence today, not how many beds exist. Ask the current clinician-to-client ratio, not the advertised one.
What Luxury Executive Rehab Costs in San Diego and What the National Pricing Data Reveals About the Premium
The ranges below are our own market estimates for the premium tier of the San Diego market, drawn from published private-pay rates and industry norms. They are not government statistics and we label them as estimates.
| Level of Care | Estimated San Diego Range | What It Should Include |
|---|---|---|
| Medical detox | $1,500–$3,500 per day | Round-the-clock nursing, physician oversight, withdrawal medication. Confirm IMS approval or hospital licensure first |
| Residential, 30 days | $45,000–$95,000 | Daily individual therapy, psychiatry, private suite, low census, dual-diagnosis programming |
| Extended residential, 60–90 days | $100,000–$250,000+ | The above plus trauma work, family and organizational reintegration, and a transition plan that is more than a folder |
| Sole-client bespoke program | $200,000+ per month | A dedicated clinical team and a private residence. Genuinely exists. Also the easiest tier in which to be quietly overcharged |
Now the number that should temper all of it. A study funded by the National Institute on Drug Abuse and published in Health Affairs collected quoted prices from residential addiction treatment facilities nationally. The average quoted daily cost was $878. For-profit facilities averaged $1,211 per day. Nonprofit facilities averaged $395. Roughly triple, for care carrying the same clinical label.
Average quoted daily cost of residential addiction treatment
Nonprofit facilities — $395
National average, all facilities — $878
For-profit facilities — $1,211
San Diego executive tier — est. $1,500–$3,500
Sources: the first three figures come from the NIDA-supported Health Affairs study reported by the National Institutes of Health. That study surveyed facilities treating adolescents, which makes it an imperfect proxy for adult executive pricing; it is offered as a directional benchmark, not an exact match. The fourth bar is our own market estimate. Bars scaled to $3,500.
The executive premium is real, it is large, and it is mostly not a clinical premium. It buys privacy, immediate admission, staffing ratios and a setting that does not feel like a punishment. For someone whose relapse risk is welded to their environment, or whose company cannot survive a visible collapse, those things carry genuine value. They are not the same thing as a better outcome, and any program implying otherwise is claiming something the evidence does not support.
How California SB 855 and Independent Medical Review Can Move Six Figures Off an Executive Treatment Bill
Most executive-tier programs in San Diego are out of network by design. That is not the end of the insurance conversation. In California it is often the beginning of it.
Federal parity is currently unsettled. The Departments of Labor, Health and Human Services and the Treasury issued an expanded MHPAEA rule in September 2024, announced in May 2025 that they would not enforce the parts new relative to the 2013 rule, and in March 2026 told the court they would not defend the 2024 rule at all. The underlying federal statute remains, but the strengthened standards are in limbo.
California state law is untouched by any of that. Senate Bill 855, effective January 2021, requires commercial plans regulated by the Department of Managed Health Care and the Department of Insurance to cover medically necessary treatment for all mental health and substance use disorders on the same terms as other medical conditions. It bars limiting coverage for chronic conditions to short-term or acute treatment. It requires plans to make level-of-care determinations using criteria from the relevant nonprofit clinical association, which for addiction means ASAM. And where medically necessary care is not available in network within the plan’s access standards, the plan must arrange out-of-network care with cost sharing capped at in-network levels.
Then there is the tool executives almost never use, largely because they assume they are above needing it. The Independent Medical Review administered by the Department of Managed Health Care is free, is usually decided within 30 days, and is binding on the health plan. By the DMHC’s own account, citing its 2024 Annual Report, in roughly 73 percent of IMR cases the denial was either reversed by the plan or overturned by the independent reviewer.
Outcome of California Independent Medical Review cases
Denial reversed by the plan or overturned by the reviewer — approx. 73%
Denial upheld — approx. 27%
Source: California Department of Managed Health Care, Independent Medical Review frequently asked questions, citing the DMHC 2024 Annual Report. Where the decision favors the member, the plan must authorize the service within five business days.
Nearly three quarters of denials do not survive independent review. Treating a first denial as final is, in California, an expensive habit. Our guide to finding high-end California rehabs that accept insurance walks through the verification-of-benefits process in more detail.
The Uncomfortable Part: Why the Traits That Make a Great CEO Make a Difficult Patient
Clinicians who work with senior executives tend to describe the same pattern, and it is worth stating plainly because no facility brochure will.
The traits that build a career at the top are, almost item for item, the traits that undermine treatment. Extreme self-reliance. A high tolerance for functioning while unwell. Fluency in managing perception. The reflex to negotiate. A lifetime of being the most capable person in the room, and of being deferred to accordingly.
Every one of those becomes a liability the moment you walk through the door. Self-reliance reads as resistance. Performance fluency lets you complete a program without ever being honest inside it. And the reflex to negotiate turns a clinical recommendation into a term sheet, which is exactly how a ninety-day stay becomes twenty-eight days and a handshake.
The programs that are genuinely good at treating executives know this and are willing to push back on you. They will tell you no. They will decline to let you take the call. Some of them will decline to admit you at all if you insist on running the company from the residence.
Here is the sharpest single filter on this page. If the admissions process feels like being sold to, walk. If it feels like being assessed, and if some of the answers you get are ones you did not want, you are probably in the right building. The best programs are not flattered by a chief executive on the phone. They are cautious about one.
What a Six-Figure Executive Program Buys, What It Provably Does Not, and Where the Evidence Actually Points
What money reliably buys. Same-day admission instead of a waitlist. A private suite. A group of six rather than thirty. More one-to-one hours. Real sleep and real food. Distance from the environment where it happened. Discretion that is architectural, not just promised. A family program that treats relatives as participants rather than visitors. For a public figure, a founder, a surgeon or anyone whose home is the trigger, none of that is vanity. It is frequently the difference between finishing and leaving on day nine.
What money does not buy. A guarantee. Substance use disorder is a chronic, relapsing condition, and price does not predict outcome. What the evidence points to is duration of engagement, medication where clinically indicated, proper treatment of co-occurring conditions, and what happens in the twelve months after discharge. A $250,000 program that hands you a discharge folder and a handshake will lose to a $20,000 program with two years of structured follow-up more often than the marketing will ever concede.
If you are only going to optimize one variable, optimize aftercare. It is the least glamorous line on the invoice and the most predictive.
Free and Confidential Resources in San Diego County Available Regardless of Income or Title
- The San Diego County Access and Crisis Line, 888-724-7240, operates 24 hours a day in more than 150 languages.
- The County’s Overdose Surveillance and Response program publishes local data and coordinates treatment referral and harm reduction.
- SAMHSA’s national helpline, 1-800-662-HELP (4357), is free and confidential around the clock.
- The 988 Suicide and Crisis Lifeline handles substance use crises as well as mental health crises.
- Licensed professionals in California, including physicians and attorneys, should ask their licensing body about confidential assistance and monitoring programs before assuming disclosure ends a career. The assumption is frequently wrong, and it is frequently fatal.
How this article was researched. Confidentiality material comes from HHS and the Office for Civil Rights on 42 CFR Part 2 and from the regulation itself. Employment protections come from the U.S. Department of Labor’s FMLA regulations and EEOC and ADA authorities. Licensing requirements come from the California Department of Health Care Services and California Health and Safety Code. Parity and appeals material comes from California SB 855, the Department of Managed Health Care, and the U.S. Department of Labor. Prevalence and treatment-gap figures come from SAMHSA’s National Survey on Drug Use and Health, with the age of the industry data disclosed at the point of use. Pricing benchmarks come from a NIDA-funded study published in Health Affairs. Every San Diego dollar range on this page is our own market estimate and is labeled as such.
If you are in crisis, call or text 988, call SAMHSA at 1-800-662-4357, or reach the San Diego County Access and Crisis Line at 888-724-7240. All are free and confidential.
References and Citations
- U.S. Department of Health and Human Services. Understanding Confidentiality of Substance Use Disorder (SUD) Patient Records, or “Part 2.” https://www.hhs.gov/hipaa/part-2/index.html
- U.S. Department of Health and Human Services. Fact Sheet: 42 CFR Part 2 Final Rule. https://www.hhs.gov/hipaa/for-professionals/regulatory-initiatives/fact-sheet-42-cfr-part-2-final-rule/index.html
- Electronic Code of Federal Regulations. 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records. https://www.ecfr.gov/current/title-42/chapter-I/subchapter-A/part-2
- Federal Register. Confidentiality of Substance Use Disorder (SUD) Patient Records, 89 Fed. Reg. 12472 (February 16, 2024). https://www.federalregister.gov/documents/2024/02/16/2024-02544/confidentiality-of-substance-use-disorder-sud-patient-records
- Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2024 National Survey on Drug Use and Health. https://www.samhsa.gov/newsroom/press-announcements/20250728/samhsa-releases-annual-national-survey-on-drug-use-and-health
- Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Substance Use and Substance Use Disorder by Industry. The CBHSQ Report. https://www.samhsa.gov/data/report/substance-use-and-substance-use-disorder-industry
- Substance Abuse and Mental Health Services Administration. National Substance Use and Mental Health Services Survey (N-SUMHSS) 2024. Publication No. PEP25-07-013. https://www.samhsa.gov/data/data-we-collect/n-sumhss-national-substance-use-and-mental-health-services-survey/annual-releases/2024
- Substance Abuse and Mental Health Services Administration. FindTreatment.gov. https://findtreatment.gov/
- National Institutes of Health. Residential Addiction Treatment for Adolescents Is Scarce and Expensive. News release, 2024. https://www.nih.gov/news-events/news-releases/residential-addiction-treatment-adolescents-scarce-expensive
- National Institute on Drug Abuse. Residential Addiction Treatment for Adolescents Is Scarce and Expensive. NIDA, 2024. https://nida.nih.gov/news-events/news-releases/2024/01/residential-addiction-treatment-for-adolescents-is-scarce-and-expensive
- California Department of Health Care Services. Facility Licensing. https://www.dhcs.ca.gov/providers-partners/facility-licensing/
- California Department of Health Care Services. Incidental Medical Services. https://www.dhcs.ca.gov/providers-partners/incidental-medical-services/
- California State Legislature. Senate Bill No. 855 (Wiener), Health Coverage: Mental Health or Substance Use Disorders, Chapter 151, Statutes of 2020. https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201920200SB855
- California Department of Managed Health Care. How to File a Complaint or Request an Independent Medical Review. https://www.dmhc.ca.gov/FileaComplaint.aspx
- California Department of Managed Health Care. Independent Medical Review and Complaint Reports. https://www.dmhc.ca.gov/fileacomplaint/independentmedicalreviewandcomplaintreports.aspx
- U.S. Department of Labor. Fact Sheet: Final Rules under the Mental Health Parity and Addiction Equity Act (MHPAEA). https://www.dol.gov/agencies/ebsa/about-ebsa/our-activities/resource-center/fact-sheets/final-rules-under-the-mental-health-parity-and-addiction-equity-act-mhpaea
- U.S. Departments of Labor, Health and Human Services, and the Treasury. Statement Regarding Enforcement of the Final Rule on Requirements Related to the Mental Health Parity and Addiction Equity Act, May 15, 2025. https://www.dol.gov/agencies/ebsa/laws-and-regulations/laws/mental-health-parity/statement-regarding-enforcement-of-the-final-rule-on-requirements-related-to-mhpaea
- U.S. Commission on Civil Rights. Substance Abuse under the Americans with Disabilities Act. https://www.usccr.gov/files/pubs/ada/ch4.htm
- County of San Diego, Health and Human Services Agency. Overdose Surveillance and Response (OSAR) Program. https://www.sandiegocounty.gov/content/sdc/hhsa/programs/phs/OSAR.html
- Internal Revenue Service. Publication 502: Medical and Dental Expenses. https://www.irs.gov/publications/p502
- Top Luxury Providers. Luxury Drug and Alcohol Rehab Centers in San Diego. https://topluxuryproviders.com/luxury-drug-and-alcohol-rehab-centers-in-san-diego/
- Top Luxury Providers. Best Way to Find High-End Drug and Alcohol Rehabs in California That Accept Insurance. https://topluxuryproviders.com/best-way-to-find-high-end-drug-and-alcohol-rehabs-in-california/
- Top Luxury Providers. The World of Elite Wellness: Inside the Most Luxurious Treatment Providers on Earth. https://topluxuryproviders.com/the-world-of-elite-wellness-inside-the-most-luxurious-treatment-providers-on-earth/
- Top Luxury Providers. How to Find High-End, Exclusive and Private Rehabs for Luxury Addiction Treatment in New Jersey. https://topluxuryproviders.com/high-end-exclusive-and-private-rehabs-for-luxuries-addiction-in-new-jersey/
- Top Luxury Providers. Discovering Top Luxury Holistic Treatment Providers Across the Globe. https://topluxuryproviders.com/discovering-top-luxury-holistic-treatment-providers-across-the-globe/
